IB

Ila Baiju Shah

Director Director DIN 01213180
DIN 01213180 First appointment Dec 1989 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 1989
Shareholding value β€’β€’β€’β€’ Premium profile

About Ila Baiju Shah

Data last updated:

Ila Baiju Shah was a Director at Parnax Lab Private Limited (1995–2010) and Director at Seezzam Pharma Private Limited (from 1989). The companies operate in Pharma.

DIN 01213180
Primary Designation Director
Industry Pharma
First Appointment 29 Dec 1989
Oldest Company Age 36 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Parnax Lab Private Limited U24239MH1995PTC088367
Director15 May 19951995Amalgamated
Seezzam Pharma Private Limited U24239MH1989PTC054705
Director29 Dec 19891989Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Seezzam Pharma Private Limited
Parnax Lab Private Limited
Premium access

Shareholding and investment profile for Ila Baiju Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ila Baiju Shah

Ila Baiju Shah was first appointed on 29 Dec 1989 as Director at Seezzam Pharma Private Limited. The most recent appointment on record is 15 May 1995 at Parnax Lab Private Limited.

Ila Baiju Shah held 2 earlier board appointments: Parnax Lab Private Limited (Director, 15 May 1995 to 15 Feb 2010); Seezzam Pharma Private Limited (Director, from 29 Dec 1989).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available